J.H. Cho

OA10.05 An Open-Label, Multicenter, Phase II Single Arm Trial of Osimertinib in NSCLC Patients with Uncommon EGFR Mutation(KCSG-LU15-09)

J.H. Cho, Jong‐Mu Sun, S. Lee et al. · Journal of Thoracic Oncology · 2018 · 16 citations · Full text

Medicine, Oncology, Pharmacotherapy +8

Transformable Gel‐to‐Nanovaccine Enhances Cancer Immunotherapy via Metronomic‐Like Immunomodulation and Collagen‐Mediated Paracortex Delivery

Seung Mo Jin, J.H. Cho, Yejin Gwak et al. · Advanced Materials · 2024 · 13 citations · Full text

Pharmacy, Immunology, Pharmaceutics +17

P3.01-023 First-line Afatinib for Non-Small Cell Lung Cancer in Real World Practice

Y. Kim, Jong‐Mu Sun, K. Park et al. · Journal of Thoracic Oncology · 2017 · 12 citations

Medicine, Oncology, Pharmacology +8